Article

Drug Therapies for the Management of Sickle Cell Disease

2020-06-11

Abstract excerpt

Sickle cell disease (SCD) afflicts millions of people worldwide but is referred to as an orphan disease in the United States. Over the past several decades, there has been an increasing understanding of the pathophysiology of SCD and its complications. While most individuals with SCD in resource-rich countries survive into adulthood, the life expectancy of patients with SCD remains substantially shorter than for t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5a72a0c5-1b01-5524-9be9-917933572c98
DOI: 10.12688/f1000research.22433.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Drug Therapies for the Management of Sickle Cell DiseaseDOI 10.12688/f1000research.22433.1Read

Current and emerging treatments for sickle cell diseaseSemantic proximity Read

Sickle Cell DiseaseSemantic proximity Read

Sickle Cell Disease.Semantic proximity Read

Emerging drugs in randomized controlled trials for sickle cell disease: are we on the brink of a new era in research and treatment?Semantic proximity Read

Biomarkers and recent advances in the management and therapy of sickle cell diseaseSemantic proximity Read

Hope on the Horizon: New and Future Therapies for Sickle Cell DiseaseSemantic proximity Read

l-Glutamine for sickle cell anemia: more questions than answersSemantic proximity Read

Hydroxyurea in the sickle cell disease modern eraSemantic proximity Read

Sickle cell disease: understanding pathophysiology, clinical features and advances in gene therapy approachesSemantic proximity Read

Optimizing hydroxyurea therapy for sickle cell anemia.Semantic proximity Read

Sickle Cell Anemia and Antisickling Agents Then and NowSemantic proximity Read

Recent Advances in the Treatment of Sickle Cell DiseaseSemantic proximity Read